BTCYBIOTRICITY INC.

Nasdaq biotricity.com


$ 1.38 $ -0.13 (-8.78 %)    

Friday, 19-Apr-2024 15:23:09 EDT
QQQ $ 414.59 $ -8.76 (-2.07 %)
DIA $ 379.83 $ 1.96 (0.52 %)
SPY $ 494.96 $ -4.36 (-0.87 %)
TLT $ 89.15 $ 0.32 (0.36 %)
GLD $ 221.02 $ 0.69 (0.31 %)
$ 1.35
$ 1.38
$ 1.34 x 200
$ 0.00 x 0
$ 1.38 - $ 1.39
$ 0.70 - $ 4.78
104,860
na
12.12M
$ 1.36
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-20-2024 12-31-2023 10-Q
2 11-14-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 06-29-2023 03-31-2023 10-K
5 02-14-2023 12-31-2022 10-Q
6 11-14-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 07-14-2022 03-31-2022 10-K
9 02-14-2022 12-31-2021 10-Q
10 11-04-2021 09-30-2021 10-Q
11 08-17-2021 06-30-2021 10-Q
12 06-22-2021 03-31-2021 10-K
13 02-16-2021 12-31-2020 10-Q
14 11-13-2020 09-30-2020 10-Q
15 08-14-2020 06-30-2020 10-Q
16 07-15-2020 03-31-2020 10-K
17 02-14-2020 12-31-2019 10-Q
18 11-14-2019 09-30-2019 10-Q
19 08-15-2019 06-30-2019 10-Q
20 07-16-2019 03-31-2019 10-K
21 02-19-2019 12-31-2018 10-Q
22 11-14-2018 09-30-2018 10-Q
23 08-14-2018 06-30-2018 10-Q
24 07-13-2018 03-31-2018 10-K
25 02-14-2018 12-31-2017 10-Q
26 11-14-2017 09-30-2017 10-Q
27 08-14-2017 06-30-2017 10-Q
28 03-30-2017 12-31-2016 10-K
29 11-18-2016 09-30-2016 10-Q
30 08-15-2016 06-30-2016 10-Q
31 05-16-2016 03-31-2016 10-Q
32 12-21-2015 11-30-2015 10-Q
33 11-30-2015 08-31-2015 10-K
34 07-14-2015 05-31-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-ultragenyx-pharmaceutical-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...

 biotricity-unveils-that-improved-margins-resulted-from-latest-advancements-to-its-proprietary-cardiac-ai-cloud-platform-and-announces-plans-for-continued-expansion-of-its-cardiac-ai-cloud

Biotricity's AI automation engine has already proven to increase operational efficiency and support growth, evidenced by th...

 biotricity-q3-2024-adj-eps-012-beats-044-estimate-sales-297m-miss-300m-estimate

Biotricity (NASDAQ:BTCY) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.44) by...

 why-fluor-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

 earnings-scheduled-for-february-20-2024

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue...

 biotricitys-earnings-outlook
Biotricity's Earnings Outlook
02/19/2024 20:01:46

 biotricity-expands-cardiac-ai-cloud-platform-development

Company's growing data ecosystem supports the development of large data models for its future predictive technologies and C...

 hc-wainwright--co-downgrades-biotricity-to-neutral

HC Wainwright & Co. analyst Kevin Dede downgrades Biotricity (NASDAQ:BTCY) from Buy to Neutral.

 earnings-scheduled-for-november-14-2023

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue o...

 earnings-outlook-for-biotricity
Earnings Outlook For Biotricity
11/13/2023 18:02:00

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION